FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study

Pérez-Ruiz, Fernando; Sundy, John S.; Krishnan, Eswar; Hingorani, V.; Welp, J.; Rodgers, Thomas D.; Manhard, Kimberly J.; Cravets, Matt; Hagerty, David; Quart, Barry

doi:10.1136/annrheumdis-2012-eular.2827

FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study

NobleIDNI8P56W23R03S66

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/856445CD.svg?ark=w1%2F20260516%2F856445CD&value=id)](https://nobleid.org/work/w1/20260516/856445CD)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study

NobleIDNI8P56W23R03S66

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/856445CD.svg?ark=w1%2F20260516%2F856445CD&value=id)](https://nobleid.org/work/w1/20260516/856445CD)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work